Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
Cancer Treatment Reviews
|
October 17, 2018
Translating the anti-myeloma activity of Natural Killer cells into clinical application
Cinzia Fionda, Helena Stabile, Rosa Molfetta, et al.
Oncoimmunology
|
April 14, 2017
Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production
Cristina Capuano, Chiara Pighi, Rosa Molfetta, et al.
International Journal of Molecular Sciences
|
February 6, 2020
CD155: A Multi-Functional Molecule in Tumor Progression
Rosa Molfetta, Beatrice Zitti, Mario Lecce, et al.
International Journal of Molecular Sciences
|
July 27, 2022
NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and Metastasis
Cinzia Fionda, Gianluca Scarno, Helena Stabile, et al.
European Journal of Immunology
|
November 28, 2022
NKG2D engagement on human NK cells leads to DNAM-1 hypo-responsiveness through different converging mechanisms
Nadia D Milito, Alessandra Zingoni, Helena Stabile, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 24, 2005
CIN85 regulates the ligand-dependent endocytosis of the IgE receptor: a new molecular mechanism to dampen mast cell function
Rosa Molfetta, Francesca Belleudi, Giovanna Peruzzi, et al.
Oncotarget
|
September 6, 2018
Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia
Veronica Martini, Federica Frezzato, Filippo Severin, et al.
Allergy
|
November 13, 2019
Immune complexes exposed on mast cell-derived nanovesicles amplify allergic inflammation
Rosa Molfetta, Mario Lecce, Linda Quatrini, et al.
Frontiers in Immunology
|
December 4, 2023
Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions
Cristina Capuano, Davide De Federicis, Daniel Ciuti, et al.
Cell Death & Disease
|
April 13, 2019
The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors
Maria Pia Abruzzese, Maria Teresa Bilotta, Cinzia Fionda, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
Cancer Treatment Reviews
|
October 17, 2018
Translating the anti-myeloma activity of Natural Killer cells into clinical application
Cinzia Fionda, Helena Stabile, Rosa Molfetta, et al.
Oncoimmunology
|
April 14, 2017
Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production
Cristina Capuano, Chiara Pighi, Rosa Molfetta, et al.
International Journal of Molecular Sciences
|
February 6, 2020
CD155: A Multi-Functional Molecule in Tumor Progression
Rosa Molfetta, Beatrice Zitti, Mario Lecce, et al.
International Journal of Molecular Sciences
|
July 27, 2022
NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and Metastasis
Cinzia Fionda, Gianluca Scarno, Helena Stabile, et al.
European Journal of Immunology
|
November 28, 2022
NKG2D engagement on human NK cells leads to DNAM-1 hypo-responsiveness through different converging mechanisms
Nadia D Milito, Alessandra Zingoni, Helena Stabile, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 24, 2005
CIN85 regulates the ligand-dependent endocytosis of the IgE receptor: a new molecular mechanism to dampen mast cell function
Rosa Molfetta, Francesca Belleudi, Giovanna Peruzzi, et al.
Oncotarget
|
September 6, 2018
Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia
Veronica Martini, Federica Frezzato, Filippo Severin, et al.
Allergy
|
November 13, 2019
Immune complexes exposed on mast cell-derived nanovesicles amplify allergic inflammation
Rosa Molfetta, Mario Lecce, Linda Quatrini, et al.
Frontiers in Immunology
|
December 4, 2023
Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions
Cristina Capuano, Davide De Federicis, Daniel Ciuti, et al.
Cell Death & Disease
|
April 13, 2019
The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors
Maria Pia Abruzzese, Maria Teresa Bilotta, Cinzia Fionda, et al.
Page
of 6